• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中的核受体:癌症治疗范式的转变

Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.

作者信息

Sajeev Anjana, BharathwajChetty Bandari, Manickasamy Mukesh Kumar, Alqahtani Mohammed S, Abbas Mohamed, Shakibaei Mehdi, Sethi Gautam, Ma Zhaowu, Kunnumakkara Ajaikumar B

机构信息

Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati (IITG), Guwahati, Assam, India.

Radiological Sciences Department, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.

出版信息

Front Oncol. 2024 Jul 15;14:1383939. doi: 10.3389/fonc.2024.1383939. eCollection 2024.

DOI:10.3389/fonc.2024.1383939
PMID:39077471
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11284039/
Abstract

Ovarian cancer (OVC) is one of the most common causes of cancer-related deaths in women worldwide. Despite advancements in detection and therapy, the prognosis of OVC remains poor due to late diagnosis and the lack of effective therapeutic options at advanced stages. Therefore, a better understanding of the biology underlying OVC is essential for the development of effective strategies for early detection and targeted therapies. Nuclear receptors (NRs) are a superfamily of 48 transcription factors that, upon binding to their specific ligand, play a vital role in regulating various cellular processes such as growth, development, metabolism, and homeostasis. Accumulating evidence from several studies has shown that their aberrant expression is associated with multiple human diseases. Numerous NRs have shown significant effects in the development of various cancers, including OVC. This review summarizes the recent findings on the role of NRs in OVC, as well as their potential as prognostic and therapeutic markers. Further, the basic structure and signaling mechanism of NRs have also been discussed briefly. Moreover, this review highlights their cellular and molecular mechanisms in chemoresistance and chemosensitization. Further, the clinical trials targeting NRs for the treatment of OVC have also been discussed.

摘要

卵巢癌(OVC)是全球女性癌症相关死亡的最常见原因之一。尽管在检测和治疗方面取得了进展,但由于诊断较晚以及晚期缺乏有效的治疗选择,OVC的预后仍然很差。因此,更好地了解OVC的生物学特性对于制定早期检测和靶向治疗的有效策略至关重要。核受体(NRs)是一个由48种转录因子组成的超家族,它们在与特定配体结合后,在调节各种细胞过程(如生长、发育、代谢和体内平衡)中发挥着至关重要的作用。多项研究积累的证据表明,它们的异常表达与多种人类疾病有关。许多NRs在包括OVC在内的各种癌症的发生发展中都显示出显著作用。本综述总结了NRs在OVC中的作用的最新发现,以及它们作为预后和治疗标志物的潜力。此外,还简要讨论了NRs的基本结构和信号传导机制。此外,本综述还重点介绍了它们在化疗耐药和化疗增敏中的细胞和分子机制。此外,还讨论了针对NRs治疗OVC的临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/2b51ebe70669/fonc-14-1383939-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/e90399acb103/fonc-14-1383939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/3c0638098fc2/fonc-14-1383939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/2b51ebe70669/fonc-14-1383939-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/e90399acb103/fonc-14-1383939-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/3c0638098fc2/fonc-14-1383939-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e66/11284039/2b51ebe70669/fonc-14-1383939-g003.jpg

相似文献

1
Nuclear receptors in ovarian cancer: changing paradigms in cancer therapeutics.卵巢癌中的核受体:癌症治疗范式的转变
Front Oncol. 2024 Jul 15;14:1383939. doi: 10.3389/fonc.2024.1383939. eCollection 2024.
2
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.核受体在肿瘤细胞可塑性和耐药性中的动态相互作用:恶性转化中的换挡和癌症治疗中的应用。
Cancer Metastasis Rev. 2024 Mar;43(1):321-362. doi: 10.1007/s10555-024-10171-0. Epub 2024 Mar 22.
3
The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.丝氨酸蛋白酶前列腺素(PRSS8)是早期检测卵巢癌的潜在生物标志物。
J Ovarian Res. 2016 Mar 31;9:20. doi: 10.1186/s13048-016-0228-9.
4
Delineating the role of nuclear receptors in colorectal cancer, a focused review.阐述核受体在结直肠癌中的作用:一篇重点综述
Discov Oncol. 2024 Feb 19;15(1):41. doi: 10.1007/s12672-023-00808-x.
5
Reversion of chemoresistance by endocannabinoid-induced ER stress and autophagy activation in ovarian cancer.内源性大麻素诱导的内质网应激和自噬激活逆转卵巢癌的化疗耐药性
Am J Cancer Res. 2023 Sep 15;13(9):4163-4178. eCollection 2023.
6
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.揭开核受体在食管癌中功能作用的神秘面纱。
Int J Mol Sci. 2022 Sep 19;23(18):10952. doi: 10.3390/ijms231810952.
7
Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects.肺癌中靶向核受体——新的治疗前景
Pharmaceuticals (Basel). 2022 May 18;15(5):624. doi: 10.3390/ph15050624.
8
Ovarian cancer molecular pathology.卵巢癌分子病理学。
Cancer Metastasis Rev. 2012 Dec;31(3-4):713-32. doi: 10.1007/s10555-012-9383-7.
9
Mast Cell-related Prognosis Signature Characterizes Immune Landscape and Predicts Prognosis of Ovarian Cancer.与肥大细胞相关的预后特征可描绘免疫图谱,并预测卵巢癌的预后。
Anticancer Res. 2024 Jul;44(7):2775-2786. doi: 10.21873/anticanres.17089.
10
Roles of Nuclear Receptors in Esophageal Cancer.核受体在食管癌中的作用。
Curr Pharm Biotechnol. 2023;24(12):1489-1503. doi: 10.2174/1389201024666230202155426.

引用本文的文献

1
Harnessing Liquiritigenin: A Flavonoid-Based Approach for the Prevention and Treatment of Cancer.利用甘草素:一种基于黄酮类化合物的癌症预防和治疗方法。
Cancers (Basel). 2025 Jul 13;17(14):2328. doi: 10.3390/cancers17142328.
2
Tackling exosome and nuclear receptor interaction: an emerging paradigm in the treatment of chronic diseases.解决外泌体和核受体相互作用:慢性疾病治疗的新兴范例。
Mil Med Res. 2024 Sep 26;11(1):67. doi: 10.1186/s40779-024-00564-1.

本文引用的文献

1
Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics.核受体在肿瘤细胞可塑性和耐药性中的动态相互作用:恶性转化中的换挡和癌症治疗中的应用。
Cancer Metastasis Rev. 2024 Mar;43(1):321-362. doi: 10.1007/s10555-024-10171-0. Epub 2024 Mar 22.
2
Delineating the role of nuclear receptors in colorectal cancer, a focused review.阐述核受体在结直肠癌中的作用:一篇重点综述
Discov Oncol. 2024 Feb 19;15(1):41. doi: 10.1007/s12672-023-00808-x.
3
Exploring the nexus of nuclear receptors in hematological malignancies.
探索核受体在血液系统恶性肿瘤中的关联。
Cell Mol Life Sci. 2024 Feb 9;81(1):78. doi: 10.1007/s00018-023-05085-z.
4
Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer.靶向治疗与免疫治疗:上皮性卵巢癌治疗中的璞玉
Front Pharmacol. 2023 Mar 24;14:1131342. doi: 10.3389/fphar.2023.1131342. eCollection 2023.
5
High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation.RARG的高表达通过调节细胞增殖加速卵巢癌进展。
Front Oncol. 2022 Nov 29;12:1063031. doi: 10.3389/fonc.2022.1063031. eCollection 2022.
6
Natural compounds targeting nuclear receptors for effective cancer therapy.靶向核受体的天然化合物在癌症治疗中的应用。
Cancer Metastasis Rev. 2023 Sep;42(3):765-822. doi: 10.1007/s10555-022-10068-w. Epub 2022 Dec 8.
7
Genenames.org: the HGNC resources in 2023.Genenames.org:2023 年的 HGNC 资源。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1003-D1009. doi: 10.1093/nar/gkac888.
8
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer.揭开核受体在食管癌中功能作用的神秘面纱。
Int J Mol Sci. 2022 Sep 19;23(18):10952. doi: 10.3390/ijms231810952.
9
Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy.以 PD-1/PD-L1 轴为卵巢癌治疗的新靶点。
Life Sci. 2022 Oct 1;306:120827. doi: 10.1016/j.lfs.2022.120827. Epub 2022 Jul 27.
10
Vitamin D and Its Receptor from a Structural Perspective.从结构角度看维生素 D 及其受体
Nutrients. 2022 Jul 12;14(14):2847. doi: 10.3390/nu14142847.